Patents Assigned to STB, Ltd
-
Publication number: 20170007742Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings, particularly for the treatment of injured tissue via endoscopic or minimally-invasive surgical techniques.Type: ApplicationFiled: September 20, 2016Publication date: January 12, 2017Applicant: STB, Ltd.Inventors: Martin MACPHEE, Belinda WILMER, Dawson BEALL, Jennifer Brichetti
-
Publication number: 20170000922Abstract: Disclosed are solid and frozen haemostatic materials and dressing's consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.Type: ApplicationFiled: September 19, 2016Publication date: January 5, 2017Applicant: STB, Ltd.Inventors: Martin MACPHEE, Jerry KANELLOS, Belinda WILMER, Dawson BEALL
-
Publication number: 20160317700Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings.Type: ApplicationFiled: July 12, 2016Publication date: November 3, 2016Applicant: STB, Ltd.Inventors: Martin MACPHEE, Dawson BEALL
-
Publication number: 20160317355Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of fibrinogen and a fibrinogen activator, wherein the fibrinogen is present in an amount between 3.0 mg/cm2 of the wound facing surface of the dressing and 13.0 mg/cm2 of the wound facing surface of the dressing. Also disclosed are methods for treating wounded tissue.Type: ApplicationFiled: July 12, 2016Publication date: November 3, 2016Applicant: STB, Ltd.Inventors: Martin MACPHEE, Dawson BEALL
-
Publication number: 20160121016Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.Type: ApplicationFiled: January 8, 2016Publication date: May 5, 2016Applicant: STB, Ltd.Inventors: Martin MACPHEE, Jerry KANELLOS, Belinda WILMER, Dawson BEALL
-
Patent number: 9259503Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.Type: GrantFiled: August 18, 2015Date of Patent: February 16, 2016Assignee: STB, LTD.Inventors: Martin MacPhee, Jerry Kanellos, Belinda Wilmer, Dawson Beall
-
Publication number: 20150352245Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.Type: ApplicationFiled: August 18, 2015Publication date: December 10, 2015Applicant: STB, LTD.Inventors: Martin MACPHEE, Jerry KANELLOS, Belinda WILMER, Dawson BEALL
-
Publication number: 20150283288Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings.Type: ApplicationFiled: June 22, 2015Publication date: October 8, 2015Applicant: STB, LTD.Inventors: Martin MACPHEE, Dawson BEALL
-
Patent number: 9131929Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.Type: GrantFiled: April 5, 2011Date of Patent: September 15, 2015Assignee: STB, Ltd.Inventors: Martin MacPhee, Jerry Kanellos, Belinda Wilmer, Dawson Beall
-
Patent number: 8445009Abstract: Disclosed are processes for preparing solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen and liquid compositions useful for preparing the haemostatic layer(s) of these dressings or for treating wounded tissue in a mammal.Type: GrantFiled: August 6, 2007Date of Patent: May 21, 2013Assignee: STB, LtdInventors: Martin MacPhee, Dawson Beall